If you assume that Ariad has identified and is well along with a Japanese partner, might that partner be active in sleuthing out and reporting the Novartis misbehavior in Japan? Certainly it would boost the partner's eventual sales effort.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.